Drug factory · FDA FEI 3002910506
Siegfried Barbera, SL
Ronda de Santa Maria 158, Barberà del Vallès, Spain
Problems found, fixed voluntarily at FDA's last inspection, Mar 30, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
3 drug inspections on record since 2014: 1 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Panobinostat | Makes it, tests it, packages it and labels it | Secura Bio, Inc. | 73116-100, 73116-101, 73116-102 |
| Tiratricol | Packages it | Rare Thyroid Therapeutics International AB | 87216-0100 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Mar 30, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Oct 11, 2018 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Jul 18, 2014 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; label; manufacture; pack.